EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient Perspectives on Reirradiation for Recurrent Cancer, to Inform Future Clinical Trial Design

F Slevin, S Kendal, A L Appelt, M Aznar, C Chan, A Duffton, C Faivre-Finn, M Harrison, S Harrow, A M Henry, E M Hudson, F Parker und 7 weitere

Clinical Oncology · 2026-08 · 56 · 104201

DOI: 10.1016/j.clon.2026.104201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Oncology, 2026-08. Verfasst von F Slevin und 18 weiteren Autor:innen. Beteiligte Einrichtung: Radiotherapy Research Group, Leeds Institute of Medical Research, University of Leeds, Leeds, West Yorkshire, UK; Leeds Teaching Hospitals NHS Trust,…. Hauptthemen laut MEDLINE: Re-Irradiation, Neoplasm Recurrence, Local, Neoplasms. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: There is increasing interest in the potential benefits of reirradiation for recurrent or new primary cancers close to or within a previously irradiated region, but there is a need for high-quality studies to evaluate this approach. This study aimed to understand patient and carer perspectives regarding reirradiation, future clinical trial design, and the potential role of advanced technologies. MATERIALS AND METHODS: Semi-structured interviews were conducted with patients who underwent reirradiation, and their carers. Patients were in follow-up and were approached about the study by their oncologist. Analysis was informed by principles of thematic analysis. RESULTS: Interviews involving 11 patients and 5 carers were conducted and analysed. Five themes were developed: 1. Considerable psychological impact from a diagnosis of recurrent cancer; 2. Influences on decision making for reirradiation; 3. Experience of reirradiation; 4. Considerations for future clinical trial design; 5. Considerations regarding advanced technologies in reirradiation. Patients and carers described the impact they had experienced from a recurrent cancer diagnosis, the strong influence of their treating oncologists on decision making regarding reirradiation, and absence of decision regret. In terms of future clinical trial design, study arms without reirradiation, especially if these contain no active treatment, may be less acceptable to patients. Some patients would be prepared to travel or temporarily relocate for reirradiation using advanced technologies such as proton beam therapy, but for others the family/social/financial impact would make this challenging. CONCLUSION: This study has provided important insights from patients and their carers regarding reirradiation for recurrent cancer. Perspectives regarding clinical trials and advanced technologies will help to shape future study design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Re-IrradiationNeoplasm Recurrence, LocalNeoplasmsHumansFemaleMaleMiddle AgedAgedClinical Trials as TopicAdult

Stichwörter der Autor:innen

Clinical trialsinterviewsproton beam therapyre-irradiationreirradiation

Autor:innen und Institutionen

  • Radiotherapy Research Group, Leeds Institute of Medical Research, University of Leeds, Leeds, West Yorkshire, UK; Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK. Electronic address: f.m.slevin@leeds.ac.uk.
  • Patient Centred Outcomes Research Group, Leeds Institute of Medical Research, University of Leeds, Leeds, West Yorkshire, UK. Electronic address: s.kendal@leeds.ac.uk.
  • Radiotherapy Research Group, Leeds Institute of Medical Research, University of Leeds, Leeds, West Yorkshire, UK; Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK. Electronic address: A.L.Appelt@leeds.ac.uk.
  • Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, Greater Manchester, UK; The Christie NHS Foundation Trust, Manchester, Greater Manch…
  • The Christie NHS Foundation Trust, Manchester, Greater Manchester, UK. Electronic address: clara.chan@nhs.net.
  • The Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow, Lanarkshire, UK. Electronic address: Aileen.Duffton@glasgow.ac.uk.

Förderung

  • NIHR

Zitieren

APA

Slevin, F., Kendal, S., Appelt, A. L., Aznar, M., Chan, C., Duffton, A., Faivre-Finn, C., Harrison, M., Harrow, S., Henry, A. M., Hudson, E. M., Parker, F., Smith, A., Spencer, K., Stephens, R., Vasquez Osorio, E., West, N., Boele, F., & Murray, L. J. (2026). Patient Perspectives on Reirradiation for Recurrent Cancer, to Inform Future Clinical Trial Design. Clinical Oncology, 56, 104201. https://doi.org/10.1016/j.clon.2026.104201

Vancouver

Slevin F, Kendal S, Appelt AL, Aznar M, Chan C, Duffton A, et al. Patient Perspectives on Reirradiation for Recurrent Cancer, to Inform Future Clinical Trial Design. Clinical Oncology. 2026;56:104201. doi:10.1016/j.clon.2026.104201

BibTeX
@article{Slevin2026,
  author = {Slevin, F and Kendal, S and Appelt, A L and Aznar, M and Chan, C and Duffton, A and Faivre-Finn, C and Harrison, M and Harrow, S and Henry, A M and Hudson, E M and Parker, F and Smith, A and Spencer, K and Stephens, R and Vasquez Osorio, E and West, N and Boele, F and Murray, L J},
  title = {Patient Perspectives on Reirradiation for Recurrent Cancer, to Inform Future Clinical Trial Design},
  journal = {Clinical Oncology},
  year = {2026},
  volume = {56},
  pages = {104201},
  doi = {10.1016/j.clon.2026.104201}
}
Kostenlos starten →